ICA was reported to reduce the expressions of Col1a1 and Acta2 in the livers from CCl4‐challenged mice (Ye et al., 2020) and ameliorate thioacetamide (TAA)‐induced liver fibrosis in rats by inhibiting hepatic Col1a1 expression and collagen deposition (Algandaby et al., 2017). Here, ACTA2 is linked to Hepatic fibrosis.